I have to respectfully disagree with part of your statement. We are DEFINITELY looking at ART numbers. Hundreds of millions along with an attractive stock price. BUT I do care about current revenues because higher revenues-> higher gross profit -> less of a hit Elite takes during the trial process. With revenues growing at this rate, Elite is put in a better financial position.

I am obviously here waiting for the grand slam, but I don't mind seeing the singles occur to get us there :)

Again, this was a great report Ryan. Thanks for your contribution on this board.

Andrew

I can only imagine how the 3rd quarter will look now :)

1.2 million! Holy mother!

Financials out!

Looking forward to the CC and earnings this week!

Not that it's a big deal or anything, just a little surprised we haven't seen a PR yet for the conference. The anticipation is killing me lol.

I've been reading all the boards daily. Lol midterms are finally over. Stocks have been horrible recently!

We're the 3 Musketeers

Nice pick up on the 20,000 shares. These prices are too tempting to buy more.

I love IPCI and all... But it's like staring at a cocoon waiting for the butterfly to hatch...

Well that gives us a beautiful looking share price :)

Thanks for sharing your opinion. In 3 years, I'll be done with Grad School. Perfect timing lol. Hopefully we stay independent and not get bought out.

Hey there Couch. Could you provide a timeline of events in terms of best case scenarios. Trials start November/December.

Best post I have seen. Thanks for doing this.

Good evening Drugdoctor!

Obviously, Elites main focus is the ART. Something that I keep on pondering about is if Elite would continue building its' revenue stream. Do you feel that they would possibly purchase even more ANDA's to continue adding to their cash flow? Possibly even doing the same thing they did with the Mikah ANDA's?

Thanks and best wishes!

Yeah it took forever for the trade to go through.

It's this morning lol. I managed to get a small position into the other stock we were talking about.

Your choice of the use of curse words are quite distasteful and make your statement less valid. I still haven't sold any of my shares. If you make money flipping these shares, I'm happy for you. Don't get me wrong, flipping could make you a ton of money. I just don't have the time to because of school. I just don't understand why you need to curse on a message board.

Just got back and thought no one had posted this. Good job Smurf! Can't complain with X>10% growth in a product .

It's been a beautiful 2 weeks for Elite. We didn't necessarily gain a whole lot, but we maintained a solid base. Very excited for the upcoming events in November.

Cough cough.... 8K is a lot for a guy my age hahaha.

How much do you have in this again? I'll go turn on the iMac right now lol

Strike 2! I'm really questioning myself why I didn't buy. I guess a good excuse would be that I've been swamped with midterms lol.

A buyout would lead to instant gratification with the maximum potential of the company not reached. Having the company stay as a single entity would/could maximize returns. Either way, an investor will be a winner with this company. Great discount price right now. Look how fast we shot up to the middle 3's! That's almost double from today's price .

Roughly November 12-15

Well to be fair, we're not alone. ZLCS is basically mirroring our one day chart today.

Looks like a huge short attack...

Holy grail!

This whole story is a little odd to me.

CPRX RSI at 28.58. SUPER LOW! Crazy low indeed.

I'm going to buy some more Monday morning. I've been very settle the past few weeks, but Elite fever hit me this weekend. Expecting the best next month.

Good evening Nasdaq,

The big month is a few weeks away. Aside from the potential/definite start of the long awaited trials, where do you see revenues hitting for the 2nd quarter report? Revenues for the 1st quarter were reported at 717K. Do you think with the adequate supplies Elite had this quarter we can achieve 900K- 1 million for the quarter? 2014 1-Q grew 41% over 2013 1-Q. That's with shortage of supplies during the 2014 quarter. I firmly believe that Elite could possibly hit those numbers this quarter. The new 15mg and 30mg Phen along with the recently launched Naltrexone will grow the numbers in a very positive way.

Less than 4 weeks away til the report!

Have a great weekend fellow long.

Arena Pharmaceuticals and Galena Pharmaceuticals. I bought Arena at $1.75 and had to deal with Adam bashing it, but in the end, the ultimately gained approval and I sold at $9.00. He I bought Galena when they were $1.18 and watched him bash it like there was no tomorrow, but similarly, I also made a gain on it and sold at $3.00. So I guess, I am 2 for 2 on making a huge gain on a stock when Adam F attacks it. Let's hope Catalyst will make it 3 for 3.

This makes it 3 stocks that Adam has hurt me with lololol

I'll go through the 10-Q's some more.

So if we end up trading 2-3 times peak sales, there is a sizable gain to be obtained. These prices are so attractive right now, just the thought of an offering is concerning.

What is the estimated market for their lead product?

I can't believe I just noticed that....

Still watching. This trading action is great for me , bad for you. I'm almost going to but. Almost there. Titan will succeed in the future.

That is why I didn't expect the update to bring a huge increase in price . We sort of expect this drug to get approved. I still think the stock will love up considerably once they obtain approval.

Alright thanks for the reply. Makes a lot more sense now.